Delivery Order SPE2DB22D3501-SPE2DB25FWD94
Award Date
6/25/25
Potential Completion Date
6/26/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XCOPRI 200 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,768.44 and a completion date of May 13, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 50 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $8,513.20 and a period of performance through June 24, 2025. The contract is designated as a firm-fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,905.84, is for the delivery of XCOPRI 100 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 20, 2025 and is a firm-fixed-price delivery order. There is no set-aside designation for this contract. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 50 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $3,536.88 and a performance period ending on June 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 50 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $3,952.38 and a performance period extending through May 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication XCOPRI 200 MG TABLET 30S, with a firm fixed price of $1,768.44 and a completion date of April 24, 2025. The contract is not set aside and was awarded on April 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for the supply of the pharmaceutical product XCOPRI 150 mg Tablet 30s, with a ceiling value of $1,615.12 and a performance period through May 15, 2025. The contract is a firm-fixed-price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XCOPRI 25 MG TABLET 30S. The contract has a firm fixed price of $1,768.44 and a performance period ending on June 6, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,768.44, is for the delivery of the pharmaceutical product XCOPRI 50 MG TABLET 30S. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed-price contract. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,178.96 delivery order contract is for the supply of XCOPRI 200 MG TABLET 30S, a pharmaceutical product. The contract has a period of performance ending on June 12, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger...